CIK 0000719135 · Non-accelerated filer<br>Smaller reporting company
Apyx Medical Corp
Sign in to watch- Ticker
- APYX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112644611
- Phone
- 7273842323
- Business address
- 5115 ULMERTON ROAD, CLEARWATER, FL, 33760
- Former names
- BOVIE MEDICAL CORP, BOVIE MEDICAL Corp, AN CON GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-15 | Levine Wendy Lauren Director | Grant or award · Stock Option (Option to Buy) | +64,000 | 64,000 | ||
| 2025-05-15 | HILL MATTHEW C Chief Financial Officer | Grant or award · Stock Option (Option to Buy) | +100,000 | 100,000 | ||
| 2025-05-15 | Goodwin Charles D. II Chief Executive Officer | Grant or award · Stock Option (Option to Buy) | +193,000 | 193,000 | ||
| 2025-05-15 | CITRONOWICZ MOSHE Sr. V.P. of Operations | Grant or award · Stock Option (Option to Buy) | +36,000 | 36,000 | ||
| 2025-05-15 | Baylor-Henry Minnie Director | Grant or award · Stock Option (Option to Buy) | +59,000 | 59,000 | ||
| 2025-01-15 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +50,000 | 50,000 | ||
| 2025-01-15 | Vizirgianakis Stavros G. Director | Grant or award · Stock Option (Option to Buy) | +50,000 | 50,000 | ||
| 2025-01-15 | Roman Shawn David Chief Operating Officer | Grant or award · Stock Option (Option to Buy) | +100,000 | 100,000 | ||
| 2025-01-15 | Levine Wendy Lauren Director | Grant or award · Stock Option (Option to Buy) | +50,000 | 50,000 | ||
| 2025-01-15 | HILL MATTHEW C Chief Financial Officer | Grant or award · Stock Option (Option to Buy) | +50,000 | 50,000 | ||
| 2025-01-15 | Goodwin Charles D. II Chief Executive Officer | Grant or award · Stock Option (Option to Buy) | +50,000 | 50,000 | ||
| 2025-01-15 | CITRONOWICZ MOSHE Sr. V.P. of Operations | Grant or award · Stock Option (Option to Buy) | +36,000 | 36,000 | ||
| 2025-01-15 | Baylor-Henry Minnie Director | Grant or award · Stock Option (Option to Buy) | +50,000 | 50,000 | ||
| 2024-08-13 | HILL MATTHEW C Chief Financial Officer | Purchase | +6,000 | $1.13 | $7K | 8,500 |
| 2024-08-13 | HILL MATTHEW C Chief Financial Officer | Purchase | +5,336 | $1.13 | $6K | 7,836 |
| 2024-08-08 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | −17,000 | 17,000 | ||
| 2024-08-08 | Swandal Craig A. Director | Grant or award · Stock Option (Option to Buy) | −17,000 | 17,000 | ||
| 2024-08-08 | Levine Wendy Lauren Director | Grant or award · Stock Option (Option to Buy) | −17,000 | 17,000 | ||
| 2024-08-08 | Vizirgianakis Stavros G. Director | Grant or award · Stock Option (Option to Buy) | −17,000 | 17,000 | ||
| 2024-08-08 | Geraghty Michael Director | Grant or award · Stock Option (Option to Buy) | −17,000 | 17,000 |
Page 2 of 7 · 131 trades